Drug Delivery and Supply Chain
Drug Delivery and Supply Chain
Samsung Bioepis and Teva expand strategic partnership to advance up to six potential biosimilar candidates
Samsung Bioepis and Teva Pharmaceutical have entered into a global licence, development and commercialisation agreement for up to six potential biosimilar candidates, with two...
Drug Delivery and Supply Chain
Bespak expands next-generation nasal offering with launch of NasaDose ultra soft unit dose spray
Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO) focused exclusively on inhaled and nasal drug delivery, will continue expansion of its next-generation nasal...
Drug Delivery and Supply Chain
Dr Oregonin completes US FDA registration for Oltis Dental-X, unveiling oral-care innovation rooted in trans-Pacific alder research
Dr Oregonin Inc has completed US Food and Drug Administration (FDA) registration for OLTIS DENTAL-X, paving the way for its official commercial entry into...
Drug Delivery and Supply Chain
Esteve CDMO expands US capacity with additional $17.5 million investment in Morton Grove
Esteve CDMO, a global pure-play CDMO specialising in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, is to spend $17.5 million on...
Technology and Automation
Hovione to commission world’s first ConsiGma CDC flex, bringing next-generation continuous tableting to the US
Hovione, a globally integrated pharmaceutical contract development and manufacturing organisation (CDMO), will commission the world's first ConsiGma CDC flex – a next generation continuous...
Drug Delivery and Supply Chain
West to highlight industry leadership in packaging and containment at CPHI worldwide
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, will highlight its leadership and expertise in addressing industry challenges at...
Drug Delivery and Supply Chain
Yourgene Health Insight DPYD assay achieves IVDR accreditation
Yourgene Health, an international molecular diagnostics company with a broad portfolio of integrated technologies and services, has announced the commercial launch of its In Vitro Diagnostic...
Drug Delivery and Supply Chain
AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer
AstraZeneca has started an exclusive licencing agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral irreversible epidermal growth factor receptor (EGFR) inhibitor for patients with lung...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
